<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0350">
 <label>70</label>
 <element-citation publication-type="journal" id="sbref0350">
  <person-group person-group-type="author">
   <name>
    <surname>Panieri</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Buha</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Telkoparan-Akillilar</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Cevik</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Kouretas</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Veskoukis</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Skaperda</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Tsatsakis</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wallace</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Suzen</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Saso</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>Potential applications of NRF2 modulators in cancer therapy</article-title>
  <source>Antioxidants</source>
  <volume>9</volume>
  <year>2020</year>
  <fpage>193</fpage>
  <pub-id pub-id-type="doi">10.3390/antiox9030193</pub-id>
 </element-citation>
</ref>
